Meta Platforms, Inc. v. Sitnet, LLC

IPR2024-00530

The PTAB issued a Final Written Decision finding that the patent claims were unpatentable by a preponderance of the evidence. The Board found obviousness over single and combined prior art references (Gage/Mitchell) for original claims, and also determined substitute claims failed both 103 and 101 standards.

Jurisdiction
US PTAB
Case Number
IPR2024-00530
Judge(s)
THU A. DANG, NEIL T. POWELL, KARA L. SZPONDOWSKI
Decision Date
27 February 2024

Detailed Summary

In this Final Written Decision, the PTAB upheld the unpatentability of the asserted claims against Sitnet, LLC. The Board found that Petitioner's arguments regarding obviousness were successful over single references like Gage for independent claims (e.g., Claim 1), and over combinations of prior art (Gage/Mitchell) for dependent claims (e.g., Claims 2, 9, 14). Furthermore, the Board denied the Patent Owner’s motion to amend, finding that all proposed substitute claims were either unpatentable under obviousness (103) or directed toward an ineligible abstract idea (101), as they merely recited routine data collection and manipulation.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Meta Platforms, Inc. vs Sitnet, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2024-00853

Abbott Diabetes Care Inc. et al.vsDexCom, Inc.

Abbott Diabetes Care successfully petitioned to institute IPR proceedings against DexCom for patent infringement related to remote patient monitoring and glucose technology. The Board found a reasonable likelihood of prevailing on multiple grounds, specifically finding that prior art combinations rendered key claims obvious under 35 U.S.C. § 103.

patentIPR2025-01103

Apple Inc.vsAdvanced Coding Technologies LLC

Apple and Advanced Coding Technologies reached a settlement, leading to the termination of an inter‑ partes review of Patent 8,230,101 B2. The Board granted the joint motion to end the proceeding and ordered the settlement documents to be kept confidential.

patentIPR2024-00621

Mito Red Light, Inc.vsJoovv, Inc.

Mito Red Light and Joovv settled their IPR dispute over U.S. Patent 11,253,719 B2, leading the PTAB to terminate the proceeding before institution.

patentIPR2024-00545

TESLA, INC.vsiQar Inc.

The PTAB found that multiple claims of the patent were unpatentable based on obviousness (35 U.S.C. § 103). The Board concluded that prior art combination with Neiss supported the modifications to the patented system, particularly regarding route handling and iterative energy calculation. Claims 1–6, 8–15, 17, and 18 were found invalid.

patentIPR2025-00380

International Business Machines CorporationvsCroga Innovations Ltd.

IBM and Croga Innovations have settled their IPR over patent 10,601,780 and jointly filed a request to keep the settlement agreement confidential. The Board is asked to treat the agreement as business confidential information and to terminate the proceeding.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call